Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Roche Holding AG

+ Add to Watchlist

RHHBY:US

35.9300 USD 0.1200 0.33%

As of 20:10:00 ET on 05/05/2015.

Snapshot for Roche Holding AG (RHHBY)

Open: 36.5150 Day's Range: 35.8100 - 36.5400 Volume: 637,544
Previous Close: 36.0500 52wk Range: 32.0800 - 38.1500 1-Yr Rtn: +2.57%

Stock Chart for RHHBY

No chart data available.
  • RHHBY:US 35.9300
  • 1D
  • 1M
  • 1Y
36.0500
Interactive RHHBY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RHHBY

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 17.8454
Relative P/E vs. SPX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2015) 1.8620
Est. PEG Ratio 3.2154
Market Cap (M USD) 247,236.19
Shares Outstanding (M) 5,620.50
30 Day Average Volume 687,483
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.79%
Cash Dividend (USD) 0.8258
Dividend Ex-Date 03/04/2015
5 Year Dividend Growth 7.33%
Next Earnings Announcement 07/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RHHBY

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for RHHBY

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Urs JaisliChief Compliance OfficerRoland DiggelmannCOO:Diagnostics
More Company Profile & Key Executives for RHHBY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil